Literature DB >> 3510926

Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin.

B Kari.   

Abstract

Cathodal iontophoresis was used to deliver insulin in 23 alloxan-diabetic, male, New Zealand white rabbits. Currents of 0.2-0.8 mA were used to deliver insulin from reservoirs containing insulin concentrations of 10-500 U/ml in aqueous solution. Regardless of the level of current used, within 1 h of turning the current on, blood glucose levels decreased and serum insulin concentrations increased. Moreover, in most cases, blood glucose levels continued to decrease and serum insulin concentrations continued to increase after the current was turned off, suggesting that iontophoresis could be used to accumulate insulin in the skin and subcutaneous tissues. The amount of insulin that was delivered by iontophoresis could be controlled by the level of current used up to 0.4 mA; increasing the current to 0.8 mA did not deliver more insulin. This may have been due to greater production of hydroxide ions at 0.8 mA, which competed with insulin to carry the current, thus slowing the movement of insulin. The amount of insulin delivered could also be controlled by the amount of insulin available for iontophoresis, i.e., as the insulin reservoir concentration increased, more insulin was delivered at the same current level. Finally, skin preparation was also important in controlling insulin delivery. To deliver enough insulin to reduce blood glucose levels, the stratum corneum had to be disrupted or removed by gentle scraping.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510926     DOI: 10.2337/diab.35.2.217

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  lontophoretic Devices for Drug Delivery.

Authors:  P Tyle
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

Review 3.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis.

Authors:  Sumeet K Rastogi; Jagdish Singh
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

5.  Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs.

Authors:  A K Banga; Y W Chien
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 6.  Transdermal iontophoresis. Pharmacokinetic considerations.

Authors:  P Singh; H I Maibach
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

Review 7.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

8.  Transport of proteins dissolved in organic solvents across biomimetic membranes.

Authors:  L E Bromberg; A M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Transport of ionic species in skin: contribution of pores to the overall skin conductance.

Authors:  E R Scott; A I Laplaza; H S White; J B Phipps
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

10.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.